vidprevtyn beta
sanofi pasteur - sars-cov-2 prefusion spike delta tm protein, recombinant (b.1.351 strain) - covid-19 virus infection - vaksiner - vidprevtyn beta is indicated as a booster for active immunisation to prevent covid-19 in adults who have previously received an mrna or adenoviral vector covid-19 vaccine (see sections 4. 2 og 5. 1 in product information document). bruk av denne vaksinen skal være i samsvar med offisielle anbefalinger.
xevudy
glaxosmithkline trading services limited - sotrovimab - covid-19 virus infection - immune sera og immunglobuliner, - xevudy is indicated for the treatment of adults and adolescents (aged 12 years and over and weighing at least 40 kg) with coronavirus disease 2019 (covid-19) who do not require oxygen supplementation and who are at increased risk of progressing to severe covid-19.
moxonidin actavis 0.2 mg
actavis group ptc ehf (1) - moksonidin - tablett, filmdrasjert - 0.2 mg
moxonidin actavis 0.4 mg
actavis group ptc ehf (1) - moksonidin - tablett, filmdrasjert - 0.4 mg
reltebon depot 20 mg
teva b.v. - oksykodonhydroklorid - depottablett - 20 mg
reltebon depot 5 mg
teva b.v. - oksykodonhydroklorid - depottablett - 5 mg
reltebon depot 10 mg
teva b.v. - oksykodonhydroklorid - depottablett - 10 mg
reltebon depot 15 mg
teva b.v. - oksykodonhydroklorid - depottablett - 15 mg
reltebon depot 30 mg
teva b.v. - oksykodonhydroklorid - depottablett - 30 mg
reltebon depot 40 mg
teva b.v. - oksykodonhydroklorid - depottablett - 40 mg